Hematopathologic findings in the myeloproliferative disorders.
JI Dickstein, JW Vardiman - Seminars in oncology, 1995 - europepmc.org
JI Dickstein, JW Vardiman
Seminars in oncology, 1995•europepmc.orgIn the preceding paragraphs, the features that define the various members of the CMPD
have been reviewed. These features are summarized in Table 4. Knowledge of these
guidelines will aid the clinician and pathologist in arriving at a proper classification;
however, in most cases, it is the occasional patient whose clinical, laboratory, and
morphologic findings lie across the different categories that unifies these CMPDs, and that
provides the challenge which makes them interesting.
have been reviewed. These features are summarized in Table 4. Knowledge of these
guidelines will aid the clinician and pathologist in arriving at a proper classification;
however, in most cases, it is the occasional patient whose clinical, laboratory, and
morphologic findings lie across the different categories that unifies these CMPDs, and that
provides the challenge which makes them interesting.
In the preceding paragraphs, the features that define the various members of the CMPD have been reviewed. These features are summarized in Table 4. Knowledge of these guidelines will aid the clinician and pathologist in arriving at a proper classification; however, in most cases, it is the occasional patient whose clinical, laboratory, and morphologic findings lie across the different categories that unifies these CMPDs, and that provides the challenge which makes them interesting.
europepmc.org